Prognostic Value of Admission Myeloperoxidase Levels in Patients With ST-Segment Elevation Myocardial Infarction and Cardiogenic Shock

American Journal of Cardiology

Volumn 101, Issue 11, 2008, Pages 1537-1540

  Dominguez Rodriguez, Alberto ^a   Samimi Fard, Sima ^a   Abreu Gonzalez, Pedro ^b   Garcia Gonzalez, Martin J ^a   Kaski, Juan Carlos ^c  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

^c ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOPEROXIDASE;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CARDIOGENIC SHOCK; CLINICAL ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY CARE UNIT; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART DEATH; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; LABORATORY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; RISK ASSESSMENT; ST SEGMENT ELEVATION; SURVIVAL RATE;

AGED; BIOLOGICAL MARKERS; CONFIDENCE INTERVALS; CORONARY CARE UNITS; DIAGNOSTIC TESTS, ROUTINE; ELECTROCARDIOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MYOCARDIAL INFARCTION; ODDS RATIO; PEROXIDASE; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SHOCK, CARDIOGENIC;

EID: 43549105099     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.02.032     Document Type: Article

References (11)

1. Nicholls S.J., and Hazen S.L. Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol 25 (2005) 1102-1111
2. Zhang R., Brennan M.L., Shen Z., MacPherson J.C., Schmitt D., Molenda C.E., and Hazen S.L. Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. J Biol Chem 277 (2002) 46116-46122
3. Brennan M.L., Penn M.S., Van Lente F., Nambi V., Shishehbor M.H., Aviles R.J., Goormastic M., Pepoy M.L., McErlean E.S., Topol E.J., et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 349 (2003) 1595-1604
4. Baldus S., Heeschen C., Meinertz T., Zeiher A.M., Eiserich J.P., Munzel T., Simoons M.L., Hamm C.W., and CAPTURE Investigators. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 108 (2003) 1440-1445
5. Tang W.H., Brennan M.L., Philip K., Tong W., Mann S., Van Lente F., and Hazen S.L. Plasma myeloperoxidase levels in patients with chronic heart failure. Am J Cardiol 98 (2006) 796-799
6. Ng L.L., Pathik B., Loke I.W., Squire I.B., and Davies J.E. Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure. Am Heart J 152 (2006) 94-101
7. Killip T., and Kimball J.T. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 20 (1967) 457-464
8. Holmes Jr. D.R. Cardiogenic shock: a lethal complication of acute myocardial infarction. Rev Cardiovasc Med 4 (2003) 131-135
9. Cavusoglu E., Chopra V., Gupta A., Ruwende C., Yanamadala S., Eng C., Clark L.T., Pinsky D.J., and Marmur J.D. Usefulness of the white blood cell count as a predictor of angiographic findings in an unselected population referred for coronary angiography. Am J Cardiol 98 (2006) 1189-1193
10. Cavusoglu E., Ruwende C., Eng C., Chopra V., Yanamadala S., Clark L.T., Pinsky D.J., and Marmur J.D. Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome. Am J Cardiol 99 (2007) 1364-1368
11. Baldus S., Rudolph V., Roiss M., Ito W.D., Rudolph T.K., Eiserich J.P., Sydow K., Lau D., Szocs K., Klinke A., et al. Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase. Circulation 113 (2006) 1871-1878